Bioavailability and Bioequivalence Services
Reliable bioavailability and bioequivalence services for seamless regulatory approval
10+ years of BA/BE study experience
Global team of experienced professionals
Regulatory approved, BA/BE centers
Expertise in pharmaceutical, biopharmaceutical, nutraceutical, and medical device studies
Strong network of experienced investigators
Regulatory-compliant services tailored to client needs
Our ISO and NABL Accredited clinical laboratories
RCS, a Contract Research Organization (CRO) based in India, USA & Europe offers a comprehensive spectrum of Bioavailability/Bioequivalence (BA/BE) services to pharmaceutical, biopharmaceutical, nutraceutical, and medical device companies. With over a decade of experience in conducting BA/BE studies, we are supported by a team of highly qualified global professionals and state-of-the-art BA/BE centers. Our network of experienced investigators ensures the delivery of high-quality, regulatory-compliant studies tailored to meet the unique needs of our clients.
Replicate Design Studies
Special Population Studies
Single and Multidose Studies
Fed and Fasting Studies
Cross-Over Studies
Bioequivalence in First-in-Human (FIH) Studies
Modified Release Studies
First-in-Human (FIH) Studies
Drug-Drug Interaction BA/BE Studies
Advancing Therapeutics with Precision and Expertise
Delivering excellence in Bio-Availability & Bio-Equivalence for global therapeutics
Study designing
ICF & protocol development
Regulatory approvals for project initiation
Pre-study approvals from IEC/IRB before project initiation
Subject recruitment & conduct of clinical phase
Bioanalytical services
Project management
Pre & post project regulatory support
Clinical data management
Statistical services
Medical writing services
Integrated report preparation
CTD/eCTD submission and CDISC data sets (SDTM and ADaM)
Data and study material archival
Global BA/BE Services
Why Choose RCS for BA/BE Studies?
Expertise Across Therapeutic Areas: With experience across a wide range of therapeutic areas, our team understands the unique challenges of each product type and tailors our approach to meet those challenges.
Global Compliance: We ensure that all studies are conducted in compliance with global regulatory standards, including those of the FDA, EMA, and other major regulatory bodies.
Comprehensive Reporting: Our detailed reporting process provides you with clear, concise, and accurate results that facilitate regulatory approval and support your product’s market success.
Patient Safety and Ethical Standards: We prioritize patient safety and adhere to the highest ethical standards in all our clinical trials, ensuring that every study is conducted with the utmost care and integrity.